Advisor Group Holdings, Inc. Vbi Vaccines Inc Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.29 - $0.64 $1,450 - $3,200	5,000 Added 60.67%	13,241 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.38 - $22.5 $167 - $9,922	-441 Reduced 5.08%	8,241 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.73 - $23.4 $8,760 - $280,800	-12,000 Reduced 58.02%	8,682 $6,000
Q2 2022 Aug 10, 2022	SELL	$0.66 - $1.81 $13,200 - $36,200	-20,000 Reduced 49.16%	20,682 $16,000
Q1 2022 May 04, 2022	SELL	$1.27 - $2.47 $2,860 - $5,562	-2,252 Reduced 5.25%	40,682 $68,000
Q2 2021 Aug 02, 2021	BUY	$2.61 - $4.17 $4,810 - $7,685	1,843 Added 4.49%	42,934 $143,000
Q1 2021 May 13, 2021	BUY	$2.91 - $4.32 $105,633 - $156,816	36,300 Added 757.67%	41,091 $127,000
Q4 2020 Feb 10, 2021	SELL	$2.15 - $3.5 $5,805 - $9,450	-2,700 Reduced 36.04%	4,791 $13,000
Q3 2020 Nov 12, 2020	BUY	$2.77 - $6.17 $9,531 - $21,230	3,441 Added 84.96%	7,491 $21,000
Q2 2020 Aug 14, 2020	SELL	$0.87 - $3.13 $2,175 - $7,825	-2,500 Reduced 38.17%	4,050 $12,000
Q1 2020 May 18, 2020	BUY	$0.73 - $1.91 $4,781 - $12,510	6,550 New	6,550 $6,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.